History & Overview
Annual Report
President's Pages
Center News
Community Affairs
Code of Conduct
Make a Gift
Cycle for Survival
Fred's Team
Yankees Universe Fund
Thomas Blake Sr. Memorial Research Fund
Donating Blood & Platelets
Volunteering
Thrift Shop
Park Avenue Potluck CELEBRATIONS
Press Releases
In the News
Information for Journalists
News@MSKCC
Manhattan
New Jersey
Long Island
Westchester
Working at Memorial Sloan-Kettering
Work Sites
College Recruitment
About Nursing
Job Fairs & Career Days
IS Careers
Job Search & Apply Online
Clinical Research Program
Brain Tumor & Central Nervous System
Breast Cancer
Colorectal Cancer
Genitourinary Cancer
Geriatrics
Gynecologic Cancer
Head and Neck Cancer
Hematology
Clinical Trials
Disease Management Team
Hepatobiliary
Infectious Disease
Integrative Medicine
Leukemia
Lymphoma
Melanoma
Pain and Palliative Care
Pediatric Cancers
Primary Bone
Psychiatry and Behavioral Sciences
Radiation Sciences
Soft Tissue Sarcoma
Thoracic
Transplantation
Upper Gastrointestinal
Home
>
Research
>
Memorial Hospital Research
>
Clinical Research Program
>
Hematology
Clinical Trials
Clicking a link below will scroll the
page down to the relevant section
Aplastic Anemia
Hematologic Disorders
Hematologic Malignancies
Multiple Myeloma
Myelodysplastic Syndrome
Aplastic Anemia
top
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor
Boulad, Farid, MD
[Protocol 01-062]
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia
Castro-Malaspina, Hugo, MD
[Protocol 06-056]
Hematologic Disorders
top
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis
Landau, Heather, MD
[Protocol 07-006]
A Pilot Trial to Assess the Feasibility and Safety of G-CSF Mobilization of Hematopoietic Stem Cells in Patients with Beta-thalassemia Major
Boulad, Farid, MD
[Protocol 08-030]
Hematologic Malignancies
top
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
Meyers, Paul, MD
[Protocol 03-123]
Multiple Myeloma
top
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
Carvajal, Richard, MD
[Protocol 09-165]
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
Landau, Heather, MD
[Protocol 09-171]
Phase III Study of Three Treatment Regimens in Patients with Previously Untreated Multiple Myeloma Who Are Not Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation
Hassoun, Hani, MD
[Protocol 08-018]
Myelodysplastic Syndrome
top
A Phase I Study of CYT 107 in Recipients of HLA-Matched T Cell-Depleted Peripheral Blood Stem Cell or Bone Marrow Transplants
VanDenBrink, Marcel, MD, PhD
[Protocol 07-127]
A Phase I Study of STA9090 in Patients with Hematologic Malignancies
Heaney, Mark, MD, PhD
[Protocol 09-095]
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
O'Reilly, Richard, MD
[Protocol 07-055]
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes
Klimek, Virginia, MD
[Protocol 06-054]
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
Boulad, Farid, MD
[Protocol 06-125]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS
[Protocol 07-072]
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor
Boulad, Farid, MD
[Protocol 01-062]
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
Castro-Malaspina, Hugo, MD
[Protocol 08-008]
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
Hsu, Katharine, MD, PhD
[Protocol 07-035]
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
Barker, Juliet, MBBS
[Protocol 08-087]
AAML0431 for the Treatment of Young Down Syndrome Children with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Shukla, Neerav, MD
[Protocol 09-080]
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy
Barker, Juliet, MBBS
[Protocol 06-014]
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated with Radiation Therapy and Chemotherapy
Correa, Denise, PhD
[Protocol 06-162]
Site Map
|
Index
Legal Disclaimer
|
Privacy Practices
|
Public Notices
©2010 Memorial Sloan-Kettering Cancer Center. 212-639-2000
1275 York Avenue New York, NY 10065.
PublicAffairs@mskcc.org